NL-OMON24921
Recruiting
Not Applicable
Reversal of opioid-induced respiratory depression (OIRD) by ketamine in healthy volunteers
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- MC
- Enrollment
- 12
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy male or female volunteers;
- •\- Age: 18 \- 40 years;
Exclusion Criteria
- •\- Known or suspected neuromuscular or a (family) history of any neuromuscular disease;
- •\- A history of allergic reaction to food or medication including study medication;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Treatment of respiratory depression from opioids in healthy volunteers and opioid usersEUCTR2021-005373-51-NLeiden University Medical Center24
Recruiting
Phase 4
Reversal of opioid-induced respiratory depression with opioid antagonists - a study in opioid naïve individuals and chronic opioid users under real-life conditionsPK en PD (farmacokinetiek en farmacodynamiek)opioid-induced respiratory depressionNL-OMON54257eids Universitair Medisch Centrum24
Active, not recruiting
Phase 1
Reversal of opioid-induced respiratory depression by ketamine in healthy volunteersRespiratory depressionMedDRA version: 19.0Level: LLTClassification code 10069144Term: Acute respiratory insufficiencySystem Organ Class: 100000004855MedDRA version: 19.0Level: LLTClassification code 10038701Term: Respiratory insufficiencySystem Organ Class: 100000004855Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2016-002148-17-NLMC12
Completed
Not Applicable
Reversal of opioid-induced respiratory depression (OIRD) by ketamine in healthy volunteers * the ORKA trialopioid-geinduceerde ademdepressieOpioid-induced respiratory depressionNL-OMON43104eids Universitair Medisch Centrum12
Completed
Not Applicable
PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY)Patients monitored by capnoGraphYJPRN-UMIN000026993Covidien Japan Inc.1,650